Recombinant Vaccinia virus Envelope phospholipase F13 (F13L), Unconjugated, E. coli

Produktübersicht

• Artikelname: Recombinant Vaccinia virus Envelope phospholipase F13 (F13L), Unconjugated, E. coli
• Artikelnummer: BIM-RPC29899
• Hersteller Artikelnummer: RPC29899
• Alternativnummer: BIM-RPC29899-20UG,BIM-RPC29899-100UG,BIM-RPC29899-1MG
• Hersteller: Biomatik Corporation
• Wirt: E. coli
• Kategorie: Proteine/Peptide
• Spezies Reaktivität: Virus
• Konjugation: Unconjugated
• Alternative Synonym: 37 kDa protein, Envelope protein F13, Palmitoylated EV membrane protein, p37K

Produktbeschreibung

Recombinant Vaccinia virus Envelope phospholipase F13 (F13L) is a purified Recombinant Protein. Purity: >90% as determined by SDS-PAGE. Host: E. coli. Endotoxin Level: Not Tested. Species: Vaccinia virus (strain IHD-J) (VACV). Target Name: Envelope phospholipase F13 (F13L) . Accession Number: P26653, F13L. Expression Region: 1-372aa. Tag Info: N-terminal 10xHis-tagged and C-terminal Myc-tagged. Theoretical MW: 49.2kda. Target Synonyms: 37 kDa protein, Envelope protein F13, Palmitoylated EV membrane protein, p37K Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Produkteigenschaften

• Molekulargewicht: 49.2kDa
• Tag: N-Terminal 10xHis-Tagged and C-Terminal Myc-Tagged
• Reinheit: >90% by SDS-PAGE
• Sequenz: MWPFAPVPAGAKCRLVETLPENMDFRSDHLTTFECFNEIITLAKKYIYIASFCCNPLSTTRGALIFDKLKEASEKGIKIIVLLDERGKRNLGELQSHCPDINFITVNIDKKNNVGLLLGCFWVSDDERCYVGNASFTGGSIHTIKTLGVYSDYPPLATDLRRRFDTFKAFNSAKNSWLNLCSAACCLPVSTAYHIKNPIGGVFFTDSPEHLLGYSRDLDTDVVIDKLKSAKTSIDIEHLAIVPTTRVDGNSYYWP
• Target-Kategorie: Envelope phospholipase F13 (F13L)